Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

My Symptoms Young - a New Internet-based Programme for Young People With Persistent Physical Symptoms in Primary Care: Exploration of Effect and Health Literacy Characteristics Among Users

NCT07912515 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2025-11-28
Last updated
2026-11-03

Condition(s) studied

Persistent Physical Symptoms (PPS)Bodily Distress SyndromeHealth LiteracyeHealth Literacy

Investigational drug(s) / intervention(s)

My Symptoms Young - an internet-based self-help programme for young people with persistent physical symptoms

My Symptoms Young - an internet-based self-help programme for young people with persistent physical symptoms: My Symptoms Young is advanced internet-based self-help programme consisting of seven modules, a closing module on relapse prevention, and a module targeting close relatives plus four tools: don't break the chain, goal setting staircase, symptom registration and notebook for reflections. The seven modules target symptom understanding, physical energy, resources and strains, thoughts, feelings, values, and self-care. The program is accessed through a website using either a computer, tablet or mobile phone.

Study summary

The research programme is an ambitious effort aiming to improve overall functioning and quality of life for young people with bodily distress. Bodily distress is a condition characterized by persistent physical symptoms (PPS), such as headache, nausea or abdominal pain, not explained by a well-defined disease. Over time, PPS can develop into a functional disorder, with detrimental impact on the young person's everyday life and opportunities. Thus, early intervention is crucial, but at present, access to specialized treatment of PPS to young people in primary care is very limited.

The investigators have developed the internet-based self-help programme My Symptoms Young as a new digital solution for early intervention of PPS. The intervention was developed using a high degree of user involvement (young people with PPS) and are now ready to be tested.

The goal of this clinical trial is to learn and preliminary test the possible effects of the internet-based self-help intervention program My Symptoms Young in young people aged 15-25 who experience PPS (physical symptoms presenting for \>3 months). The main question the investigators aim to answer is:

* What are the potential effects of My Symptoms Young In addition, the investigators aim to investigate if participation in the program can reduce overall symptom intensity and interference with daily activity in young people's lives. Finally, the investigators aim to examine if individual levels of health literacy (HL) and eHealth literacy (eHL) will modify the potential effects.
* The primary outcomes will be symptom intensity and symptom interference with daily activities
* The primary hypothesis will be: Symptom intensity and interference with daily activities will improve after the treatment with My Symptoms Young. The effect will be modified by levels of HL and aspects of eHL.

The investigators will include a total of 62 participants. The are no comparison group. Participants will be recruited from a health care professional in primary care (either general practitioner or practising pediatrician; from now on referred to as HCP). The HCP will determine whether referral to the My Symptoms Young programme is relevant. To guide this evaluation, the HCP will use pre-defined inclusion and exclusion criteria for participation. When a young person has been referred to the project group, a research assistent from the investigator group will contact the young person to provide more detailed information on the research project and the programme. If written consent is obtained, the young person will receive access to the programme. Throughout the intervention, the referring HCP is fully responsible for the health care of the young person. Referral and participation will be documented in the participants' primary care medical journal. If participants experience physical or psychological challenges during the project, they are advised to contact the referring HCP, i.e. the responsible healthcare provider.

The programme is accessed through a website, using either tablet, mobile or computer. It consists of seven modules, a closing module on relapse prevention, and a module targeting close relatives plus four tools: don't break the chain, goal setting staircase, symptom registration and notebook for reflections. The seven modules target symptom understanding, physical energy, resources and strains, thoughts, feelings, values, and self-care. Participants will gradually gain access to the modules. The programme encourages young persons to work with various exercises throughout the different modules but with freedom to choose what to work with. Besides text and exercises, the programme also includes explanatory animations, audio files on case stories, audio files on brief meditations and videos on physical exercises.

At first login (baseline), the participant will need to complete a set of questionnaires to access the programme. When completed the participant receives access to the programme. The researcher will follow up with participants by phone after one week if they have not logged into the programme and after three weeks if they have logged in but remained inactive. Participants can decide individually how long they wish to use the programme, but they are encouraged and recommended to engage actively at least twice a week for a minimum of 30 minutes. Participants will have access to the program for a total of 8 weeks. They will fill in questionnaires at three time points: Baseline (first login to the programme), End of Treatment (8 weeks after baseline) and 3 months after End of Treatment.

Eligibility

Sex
ALL
Min age
15 Years
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria: * Age: 15-25 years * Persistent or recurrent physical symptoms (PPS) ≥ 3 months * Average symptom intensity and interference of ≥ 3 on the NRS scale (0-10) * PPS affecting daily activities (e.g. school attendance, social activities, hobbies) * Symptoms are not explained by existing physical disease * Reads, speaks, and understands Danish Exclusion Criteria: * Severe psychiatric or social problems (e.g. acutely suicidal, psychotic) * Problematic use of alcohol or drugs * Insufficient digital skills

Primary outcome measure(s)

  • Symptom intensity and interference — Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment
    The primary outcomes will be symptom intensity and symptom interference with daily activities as measured by a numeric rating scale (NRS) ranging from 0 to 10. For symptom intensity, the young person rates the overall intensity of their bodily symptoms within the past 7 days where 0 represents 'no symptoms at all' and 10 'worst possible symptoms'. For symptom interference, the young person indicates their bodily symptoms' interference with daily activities within the past 7 days, 0 will represent 'Not at all' and 10 'Interfered completely'

Trial sites (1)

FacilityCityRegionStatus
Aarhus University Hospital Aarhus Denmark Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07912515 on ClinicalTrials.gov ↗ ← All trials in Denmark